Henning Mallwitz

Title: Henning Mallwitz: Innovator in Topical Pharmaceutical Compositions

Introduction

Henning Mallwitz is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions for various skin disorders. With a total of 2 patents, his work has had a meaningful impact on dermatological treatments.

Latest Patents

Mallwitz's latest patents include innovative formulations aimed at treating skin conditions. One of his notable inventions is a topical pharmaceutical composition that comprises 0.01 to 0.2 wt. % of mometasone furoate, 5 to 18 wt. % of hexylene glycol, 20 to 40 wt. % of water, and 25 to 70 wt. % of an oil phase. This composition is designed to be stable and can be safely applied over large surface areas of the skin, making it suitable for the treatment or prevention of psoriasis, atopic dermatitis, and other skin disorders. Another significant patent is a topical gel composition for the treatment of actinic keratosis, which includes an active agent for treatment, a keratolytically active agent, a gel former, and an organic solvent.

Career Highlights

Throughout his career, Mallwitz has worked with prominent companies in the pharmaceutical industry, including Almirall Hermal GmbH and Almirall, S.A. His experience in these organizations has allowed him to refine his expertise in developing effective topical treatments.

Collaborations

Mallwitz has collaborated with notable colleagues such as Christoph Willers and Manfred Melzer. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Henning Mallwitz is a distinguished inventor whose work in topical pharmaceutical compositions has made a significant impact on the treatment of skin disorders. His innovative patents reflect his commitment to improving patient care and advancing pharmaceutical science.